ARTICLE | Distillery Therapeutics
Cancer
December 6, 2016 7:37 PM UTC
Cell culture studies suggest inhibiting CHD4 could help treat PAX-FOX1 fusion gene-positive rhabdomyosarcomas. In two human rhabdomyosarcoma cell lines positive for the PAX-FOX1 fusion oncogene, shRNA...
BCIQ Company Profiles